AU2317477A - Polypeptides for treating schizophrenia - Google Patents

Polypeptides for treating schizophrenia

Info

Publication number
AU2317477A
AU2317477A AU23174/77A AU2317477A AU2317477A AU 2317477 A AU2317477 A AU 2317477A AU 23174/77 A AU23174/77 A AU 23174/77A AU 2317477 A AU2317477 A AU 2317477A AU 2317477 A AU2317477 A AU 2317477A
Authority
AU
Australia
Prior art keywords
polypeptides
treating schizophrenia
schizophrenia
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU23174/77A
Other versions
AU510679B2 (en
Inventor
C. E Frohman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stateof Michigan
Original Assignee
Stateof Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/772,851 external-priority patent/US4146614A/en
Application filed by Stateof Michigan filed Critical Stateof Michigan
Publication of AU2317477A publication Critical patent/AU2317477A/en
Application granted granted Critical
Publication of AU510679B2 publication Critical patent/AU510679B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU23174/77A 1976-03-23 1977-03-11 Polypeptides for treating schizophrenia Expired AU510679B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US66952676A 1976-03-23 1976-03-23
USUS669526 1976-03-23
US05/772,851 US4146614A (en) 1976-03-23 1977-02-28 Threonyl-valyline leucine containing peptides and pharmaceutical compositions
USUS772351 1977-02-28

Publications (2)

Publication Number Publication Date
AU2317477A true AU2317477A (en) 1978-09-14
AU510679B2 AU510679B2 (en) 1980-07-10

Family

ID=27100128

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23174/77A Expired AU510679B2 (en) 1976-03-23 1977-03-11 Polypeptides for treating schizophrenia

Country Status (13)

Country Link
JP (1) JPS52142015A (en)
AU (1) AU510679B2 (en)
CA (1) CA1103239A (en)
DE (1) DE2712781A1 (en)
DK (1) DK125177A (en)
FR (1) FR2351954A1 (en)
GB (1) GB1561247A (en)
GR (1) GR63642B (en)
LU (1) LU76998A1 (en)
NL (1) NL7703124A (en)
NO (1) NO771031L (en)
NZ (1) NZ183627A (en)
SE (1) SE7702925L (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986003746A1 (en) * 1984-12-14 1986-07-03 La Trobe University Amino acid and peptide inhibitors of human leucocytic elastase

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03236315A (en) * 1989-12-05 1991-10-22 Nippon Oil & Fats Co Ltd Antipsychotic agent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986003746A1 (en) * 1984-12-14 1986-07-03 La Trobe University Amino acid and peptide inhibitors of human leucocytic elastase

Also Published As

Publication number Publication date
AU510679B2 (en) 1980-07-10
CA1103239A (en) 1981-06-16
DE2712781A1 (en) 1977-10-06
GR63642B (en) 1979-11-27
NO771031L (en) 1977-09-26
NL7703124A (en) 1977-09-27
FR2351954A1 (en) 1977-12-16
LU76998A1 (en) 1977-10-03
GB1561247A (en) 1980-02-13
SE7702925L (en) 1977-09-24
DK125177A (en) 1977-09-24
JPS52142015A (en) 1977-11-26
NZ183627A (en) 1980-02-21
FR2351954B1 (en) 1980-03-28

Similar Documents

Publication Publication Date Title
PH16149A (en) Aminoalkyl substituted heterocycles
ZA776316B (en) Control means
CA1029834A (en) System for controlling two variables
JPS52110795A (en) Process for polyynnbutene
AU509113B2 (en) Rom-intializing apparatus
IL51429A (en) Coccidiocidal composition for treating
AU497355B2 (en) Spray apparatus for refractory material
AU520676B2 (en) Control circuits
AU510679B2 (en) Polypeptides for treating schizophrenia
AU514965B2 (en) Polypeptide derivatives
GB2025230B (en) Control circuits for electrosurgicaldevices
SU578093A1 (en) Gas-cleaning apparatus
SU644888A1 (en) Fabric-impregnating apparatus
AU3087777A (en) Phoshating process
AU508751B2 (en) Azamethine-cu complex compounds
SU615981A1 (en) Pressure-determining apparatus
SU587239A1 (en) Casing-cementing apparatus
SU592407A1 (en) Fodder-preparing apparatus
SU601191A1 (en) Article-indexing apparatus
SU573157A1 (en) Compressing-distracting apparatus
SU625023A1 (en) Casing-cementing apparatus
SU629966A1 (en) Material-crushing apparatus
SU649490A1 (en) Tube-working apparatus
AU512369B2 (en) Package-dispenser for mips
JPS52155383A (en) Aparratus for crossslinking